These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 6797270
1. [Adrianycin as intracavitary coadjuvant treatment of superficial bladder tumors. Our initial experiences]. Martínez Lasierra M, Caro Cebrián C, Sanz Vélez JI, Roncalés A, Rioja Sanz C. Actas Urol Esp; 1981; 5(4):219-22. PubMed ID: 6797270 [No Abstract] [Full Text] [Related]
2. [Preliminary results of a randomized study between intravesical adriamycin and thio-tepa in the treatment of superficial tumors of bladder]. Allona Moncada A, Santos García Vaquero I, Polo Villar G, Díaz González R, González Martín M, Zuloaga Gómez A, Martínez Torres JL, Rodríguez Alvarez J, Duarte Vázquez JJ, Megino López JF. Arch Esp Urol; 1984; 37(2):113-22. PubMed ID: 6431914 [No Abstract] [Full Text] [Related]
3. Intravesical chemotherapy in the management of superficial bladder tumors. Schulman CC. Prog Clin Biol Res; 1984; 153():275-85. PubMed ID: 6433356 [No Abstract] [Full Text] [Related]
4. Thiotepa versus adriamycin versus cis-platinum in the intravesical prophylaxis of superficial bladder tumors. Llopis B, Gallego J, Mompó JA, Boronat F, Jiménez JF. Eur Urol; 1985; 11(2):73-8. PubMed ID: 3924624 [Abstract] [Full Text] [Related]
5. [Comparative study of thiotepa and adriamycin as preventive intravesical treatment in non-infiltrating bladder tumors]. Lancina Martín JA, Mateo Cambón L, Casas Muiño RA, González Martín M. Actas Urol Esp; 1983; 7(4):269-74. PubMed ID: 6414263 [No Abstract] [Full Text] [Related]
7. [Prevention of the recurrence of bladder tumors with local adriamycin therapy]. Somogyi L, Török A, Bors G, Frang D. Orv Hetil; 1984 Oct 07; 125(41):2503-6. PubMed ID: 6493764 [No Abstract] [Full Text] [Related]
8. [Intravesical chemical prevention of recurrence of superficial urothelial bladder cancer. Progress report of the Urology Clinic of Mainz University 1975-1981]. Jacobi GH, Engelmann U, Frohneberg D, Thüroff JW. Helv Chir Acta; 1982 Aug 07; 49(3-4):345-8. PubMed ID: 6813292 [No Abstract] [Full Text] [Related]
9. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis. Huncharek M, McGarry R, Kupelnick B. Anticancer Res; 2001 Aug 07; 21(1B):765-9. PubMed ID: 11299841 [Abstract] [Full Text] [Related]
13. [Prognostic factors and risk of recurrence in a series of 385 patients with superficial bladder carcinoma treated with thiotepa, adriamycin or cisplatin]. Llopis B, Sánchez A, Boronat F, Gallego J, Moreno B, Alonso M, Martínez R, Vera CD, Jiménez JF. Arch Esp Urol; 1987 Apr 07; 40(3):159-64. PubMed ID: 3113347 [No Abstract] [Full Text] [Related]
14. Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study. Ali-el-Dein B, el-Baz M, Aly AN, Shamaa S, Ashamallah A. J Urol; 1997 Jul 07; 158(1):68-73; discussion 73-4. PubMed ID: 9186325 [Abstract] [Full Text] [Related]
15. Use of intravesical thiotepa in superficial bladder tumours. Kulkarni JN, Kamat MR, Juvekar RL. Indian J Cancer; 1981 Sep 07; 18(3):222-4. PubMed ID: 6796504 [No Abstract] [Full Text] [Related]
19. Chemotherapy of bladder cancer: a review. Smith PH. Cancer Treat Rep; 1981 Sep 07; 65 Suppl 1():165-73. PubMed ID: 6799197 [Abstract] [Full Text] [Related]
20. [Characteristic and effective usage of adriamycin]. Horiuchi K, Akimoto M. Gan To Kagaku Ryoho; 1996 Dec 07; 23(14):1916-9. PubMed ID: 8978797 [Abstract] [Full Text] [Related] Page: [Next] [New Search]